300267 尔康制药
2024/03 -
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资119,901-0.27%120,229138,968146,158155,958
投资性房地产80,487-0.99%81,28885,26388,65692,048
固定资产2,576,142-0.07%2,577,8322,681,7091,983,7212,618,008
在建工程221,2570.17%220,89052,917506,179408,205
无形资产372,250-1.53%378,034406,136431,447553,348
商誉2,0030.00%2,00310,00810,00823,842
其他非流动资产364,376-0.93%367,778389,666319,445119,810
3,736,416-0.31%3,748,0553,764,6683,485,6143,971,218

流动资产
货币资金535,044-28.12%744,350764,669761,564883,225
应收账款108,797-0.33%109,154133,693186,496353,786
存货701,2951.40%691,603821,345714,772756,059
其他流动资产380,306104.57%185,907371,497283,533692,702
1,725,441-0.32%1,731,0142,091,2041,946,3652,685,773

流动负债
短期借款351,0262.67%341,889396,641246,000463,000
应付票据0--0000
应付帐款157,39928.70%122,299198,705137,871152,233
其他流动负债111,802-19.63%139,113130,087115,056140,544
620,2282.81%603,301725,433498,926755,777
流动资产净值1,105,213-2.00%1,127,7131,365,7711,447,4391,929,996
资产总额减流动负债4,841,629-0.70%4,875,7685,130,4394,933,0535,901,214

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债65,753-0.00%65,75479,13559,35163,058
65,753-0.00%65,75479,13559,35163,058

总权益
    实收股本2,062,6050.00%2,062,6052,062,6052,062,6052,062,605
    储备项目2,742,477-1.12%2,773,4412,988,4262,788,6073,748,437
股东权益4,805,082-0.64%4,836,0465,051,0314,851,2115,811,042
非控股权益(29,205)12.19%(26,032)27322,49027,114